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Abstract 
To facilitate characterization f mutated cytochrome bCl complexes in S. cerevisiae we have developed a new approach 
using a rapid scanning monochromator to examine pre-steady-state reduction of the enzyme with menaquinol. The RSM 
records optical spectra of cytochromes b and C l at 1-ms intervals after a dead time of 2 ms, and menaquinol fully reduces 
both cytochromes bH and c~ and a portion of cytochrome bL. The rapid-mixing, rapid-scanning monochromator 
methodology obviates limitations inherent in previous rapid kinetics methods and permits measurements of rates exceeding 
200 s-~. To document the validity of this methodology we have examined the reduction kinetics of the cytochrome bCl 
complexes from wild-type yeast and yeast hat lack ubiquinone. The results establish that menaquinol reacts via the Q cycle 
pathway both in the presence and absence of ubiquinone. From analyzing bc~ complexes containing Rieske proteins in 
which the midpoint potential of the iron-sulfur cluster has been altered from +280 to + 105 mV, we propose a mechanism 
in which the protonated quinol displaces a proton from the imidazole nitrogen of one of the histidines that is a ligand to the 
iron-sulfur cluster and forms a quinol-imidazolate complex that is the electron donor to the redox active iron. © 1998 
Elsevier Science B.V. 
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1. Introduction 
To facilitate characterization of cytochrome bc~ 
complexes, in which the kinetic properties of the 
enzyme have been altered by site-directed muta- 
genesis of the genes in S. cerevisiae, we have 
developed a new approach using a rapid-scanning 
monochromator t  examine pre-steady-state reduction 
of the enzyme on a ms time scale after initiating 
reduction of the enzyme with menaquinol. The rapid- 
CoiTespondmg author. 
scanning monochromator allows simultaneous moni- 
toring of the pre-steady-state r duction of cyto- 
chromes b and c 1 with a time resolution of 1 ms after 
a dead time for mixing of 2 ms, and the potential of 
menaquinol is low enough to permit partial reduction 
of cytochrome b L in addition to cytochromes b H and 
c~. Although rapid scan spectrophotometry has re- 
cently been applied to the bovine bc 1 complex [9], 
the kinetic measurements were limited by a relatively 
slow 25-ms mixing time and were restricted to 
examination of the oxidation kinetics due to the lack 
of a suitably low potential quinol substrate. Photo- 
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synthetic reaction centers have also been used to 
drive reduction of the bc~ complex with responses in 
the ms time range [4,13], but this approach is limited 
by the fact that a single flash incompletely reduces 
the cytochromes, and multiple flashes elicit simulta- 
neous reoxidation and reduction. The rapid-mixing, 
rapid-scanning monochromator (RMRSM) meth- 
odology described here obviates all of these problems 
and permits measurements of rates exceeding 200 
-1  
S 
2. Results and discussion 
Menaquinol was chosen as a substrate for reduc- 
tion of the bc~ complex because it is more strongly 
reducing (Em7=-74 mV, Ref. [6]) than ubiquinol 
(EmT=q-90 mV, Ref. [10]), allowing a greater per- 
centage of cytochrome b to be reduced under equilib- 
rium conditions. Menaquinol has the additional ad- 
vantage that the quinol, but not the quinone form, is 
soluble at high concentrations in aqueous olutions, 
thus obviating problems that might result from the 
use of organic solvents. From the optical spectra in 
Fig. 1A one can calculate that menaquinol completely 
reduced cytochrome c I and approximately 70% of the 
dithionite reducible cytochrome b. This result is in 
agreement with the midpoint potentials of 
menaquinol and the b cytochromes (bH= +90 mV and 
bL=-30  mV; Ref. [2,10]). At pH 6.0, the predicted 
extent of reduction of b H is >99% and b L is 
approximately 20%. Assuming that b H and b e con- 
tribute 70 and 30%, respectively, to the total ab- 
sorbance change at 563 nm, and that the midpoint 
potential of the b cytochromes i pH independent 
[12]), the predicted reduction of cytochrome b is 
76%, close to the 70% observed experimentally. 
Eh, and not E m, of the menaquinol/menaquinone 
couple should be the parameter that determines the 
extent of b L reduction. However, the observed extent 
of reduction more closely agrees with what would be 
predicted from the E m than from the E h. This may 
indicate that the reported E m of menaquinol [6] is 
incorrect, with the consequence that the observed 
extent of reduction would agree more closely with 
E h. However, we have observed that the extent of b 
reduction with ubiquinol as substrate also agrees with 
the E m of the ubiquinol/ubiquinone couple rather 
than with the E n (results not shown). An alternative 
explanation for the less than predicted reduction of 
cytochrome b is that the extent of reduction of the b 
hemes through the enzyme-catalyzed pathways does 
not respond to the potential (E h) of the quinol/ 
quinone pool in the absence of mediators. 
The traces in Fig. 1B illustrate time-resolved 
optical spectra collected by the rapid-scanning mono- 
chromator. In this experiment the bc 1 complex was 
reduced with a very low concentration (6 IxM) of 
menaquinol in order to extend the reaction over 
several seconds. Following a 2-ms dead time, the 
RSM collects optical spectra every 1 ms, but only 40 
spectra, at 50-ms intervals, are displayed in this 
figure. This low concentration f menaquinol permits 
a clear display of the triphasic reduction of cyto- 
chrome b (see Ref. [2] for a review) when the 
three-dimensional d ta from Fig. 1B are analyzed at 
the wavelength diagnostic of cytochrome b, as shown 
in Fig. 2. The inset in Fig. 2 shows the first spectra 
collected in real time during triphasic reduction, and 
spectra averaged over 10-ms intervals confirm that 
cytochrome b undergoes partial reoxidation. 
As a prerequisite to using RMRSM to dissect he 
kinetics in genetically engineered bc I complexes we 
performed control experiments to establish that 
menaquinol reacts through center P in the Q cycle 
pathway, and alternatively can reduce the b cyto- 
chromes through center N if center P is blocked. For 
this purpose we examined the effects of center N and 
center P inhibitors on the reduction of cytochromes b 
and c 1. The time course of reduction of the cyto- 
chrome bcl complex when it is rapidly mixed with 
menaquinol is shown in Fig. 3. In the absence of 
inhibitors, both cytochromes b and c 1 are reduced by 
50 IxM menaquinol within 1 s. When the center P 
inhibitor stigmatellin was added it blocked the reduc- 
tion of cytochrome c I (Fig. 3, middle panel), and 
when both stigmatellin and the center N inhibitor 
antimycin were added, they blocked the reduction of 
both cytochromes b and c 1 (Fig. 3, bottom panel). 
These results establish that menaquinol cannot bypass 
these center P and center N inhibitors. 
That menaquinol reacts enzymatically through the 
Q cycle pathway was confirmed using the Rieske 
iron-sulfur protein S183C mutant [3]. In this mutant, 
the Rieske apoprotein is stably incorporated into the 
cytochrome bc I complex, even though it lacks the 
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Fig, 1. (A) Optical spectra of 2 I~M purified yeast cytochrome bc~ complex after reduction with 50 I~M menaquinol (MQ) or dithionite (DT). Oxidized 
cytochrome bc 1 complex in 100 mM sodium phosphate, pH 6.0, containing 2 mM EDTA and 0.1 mg/ml dodecyl maltoside was reduced with menaquinol 
or dithionite and the resulting difference spectra of reduced versus oxidized enzyme were recorded in the split beam mode at 0.5-nm intervals with an 
Aminco DW 2A spectrophotometer equipped with an On-Line Instruments Systems, Inc. computer interface. (B) Time-resolved optical spectra obtained by 
stopped-flow rapid scanning spectrophotometry during reduction of the bc 1 complex by menaquinol. In this experiment 2 ~M bc I complex was reduced by 
rapid mixing with 6 txM menaquinol. Spectra were recorded on an OLIS rapid-scanning monochromator equipped with a 1200qine/mJn grating blazed at 
500 nm, which yields a spectrum of 75 nm width at a resolution of 0.4 nm. Data were collected at 1000 scans/s, and the spectra were centered at 555 nm. 
The dead time of the stopped-flow mixer is approximately 2 ms, and the end of this period was chosen as time zero. 
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Fig. 2. Triphasic reduction of cytochrome b observed by time-resolved optical spectra obtained uring reduction of cytochromes b and c~ by menaquinol. 
The traces at 563.3 and 554.6 nm were derived from the three-dimensional d ta set shown in Fig. lB. The inset shows time-averaged optical spectra 
obtained across the 10-ms intervals indicated by the solid bars at points A, B, and C at 150 and 555 ms and at 4 s during the reaction. 
iron-sulfur cluster. The absence of functional iron- 
sulfur protein will block enzymatic oxidation of 
menaquinol at center P, but should allow reduction of 
cytochrome b through center N. In this mutant we no 
longer observed reduction of cytochrome c~ by 
menaquinol (data not shown), and in the presence of 
antimycin reduction of cytochrome b was also 
blocked (data not shown). These results confirm that 
menaquinol reduces the cytochrome bc~ complex 
through its enzymatic pathways, and validate the use 
of menaquinol as a reductant to study the kinetics of 
electron transfer within the cytochrome bc~ complex. 
The concentrations of menaquinol used in these 
reactions (<100 t~M) are less than saturating, so that 
the pre-steady-state kinetics are second order. Varying 
the concentration f menaquinol ver a 20-fold range 
in the presence of either antimycin or stigmatellin, 
and fitting of the kinetic data, allowed the calculation 
of second-order rate constants for reduction of both 
cytochromes b and c I through center P and for 
reduction of cytochrome b through center N. The 
rates of cytochrome b reduction through center P are 
best fitted by a two-component curve, consisting of a 
fast and a slow phase with second-order rate con- 
stants of 1.3)<106 and 8.8×104 M -1 s -~. As shown 
in Fig. 4, reduction of cytochrome c l is kinetically 
matched to the second, slow phase of b reduction, 
with a rate constant of 7.5X10 ~ M -I s -~ One 
explanation for these results is that when the first 
molecule of menaquinol is oxidized one electron 
equilibrates between iron-sulfur protein and cyto- 
chrome c~, and the second electron is transferred to 
cytochrome b. Under the conditions used in these 
experiments, the midpoint potential of the iron-sulfur 
protein is >60 mV more positive than that of 
cytochrome c~, with the result that the electron from 
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Fig. 3. Reduction of the cytochrome bc, complex through center P and center N by menaquinol. The top panel shows reduction of 2 FM bc, complex by 
50 p,M menaquinol in the absence of inhibitors. The middle panel shows the inhibition of c, reduction by stigmatellin, and the bottom panel shows the 
inhibition of b and c, reduction by stigmatellin plus antimycin. 
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Fig. 4. Kinetics of reduction of the cytochrome bc 1 complex by menaquinol through center P. The traces in A show the time course of reduction of 
cytochrome b and cytochrome c I when 2 IxM cytochrome bc~ complex is reduced by 50 I~M menaquinol in the presence of antimycin. The plot in (B) 
shows the effects of increasing menaquinol concentration  the rates of reduction of cytochrome b and cytochrome cl. The inset shows the effects of 
increasing menaquinol concentration on the slow rates of cytochrome b and cytochrome c~ reduction. 
the first molecule of menaquinol oxidized is predomi- 
nately located in the iron-sulfur protein. Only when 
the first electron is localized to c 1 can the second 
molecule of menaquinol be oxidized and transfer 
electrons to iron-sulfur protein and cytochrome b. 
This mechanism is consistent with the results where 
the slow rate of b reduction matches the rate of 
cytochrome c I reduction. 
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From the traces in the top panels of Figs. 4 and 5, 
which show reduction of cytochrome b through 
center P and center N with 50 ~M menaquinol, it
appears that the former reaction is significantly faster 
than the latter. This was confirmed by the second- 
order rate constant for the reaction through center N, 
2.5× 105 M -~ s -~ (Fig. 5, bottom panel). This 5-fold 
difference in rates through center P and center N 
indicates that these rates are primarily governed by 
the thermodynamics of the electron transfer eactions. 
This is consistent with the notion that the reactive 
head group of ubiquinone can remain resident in the 
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Fig. 5. Kinetics of reduction of cytochrome b by menaquinol through center N. The trace in A shows the time course of reduction of cytochrorne b when 2 
p~M cytochrome bc~ complex is reduced by 50 txM menaquinol in the presence of stigmatellin. The plot in (B) shows the effects of increasing menaquinol 
concentration on the rate of reduction of cytochrome b through center N. 
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bc~ complex for multiple turnovers of the enzyme, 
and that the accessibility of quinone to the two sites 
is essentially identical. 
The preceding kinetic analysis also indicated that 
there was a secondary, slow reduction of cytochrome 
c~, which occurred at a rate of <0.01 s ], and this 
slow reduction was also observed in the presence of 
stigmatellin. Cytochrome c~ was also slowly reduced 
in the Rieske iron-sulfur protein S183C mutant, 
which indicates that menaquinol can directly reduce 
cytochrome c l in an iron-sulfur protein-independent 
manner. However, this non-enzymatic rate is several 
orders of magnitude slower than the iron-sulfur 
protein-catalyzed reduction of cytochrome c~ through 
center P, and it does not impact on the kinetics of 
cytochrome c~ reduction, even when these rates are 
lowered 10-fold by mutational changes in the iron- 
sulfur protein. 
We have also examined the reduction kinetics of 
the cytochrome bc~ complex from yeast mutants that 
lack endogenous ubiquinone (Fig. 6). The RMRSM 
analysis of the isolated bc~ complex reveals indi- 
vidual properties of the two quinol/quinone oxido- 
reductase sites, center P and center N, in their 
reactivities with menaquinol and menaquinone. Re- 
duction of the cytochromes b and c] through center P 
and reduction of cytochrome b through center N by 
menaquinol in the absence of ubiquinone is inhibited 
by stigmatellin (Fig. 6, middle panel) and antimycin 
(Fig. 6, bottom panel). 
The reactivity of menaquinol with bc~ complex 
lacking ubiquinone may lead to some novel insights 
into the mechanism of triphasic reduction of cyto- 
chrome b. Notably, concentrations of menaquinol that 
result in triphasic reduction of cytochrome b when 
ubiquinone is present (Fig. 3, top panel), result in 
apparently monophasic b reduction when ubiquinone 
is absent (Fig. 6, top panel), and the rate closely 
matches the first, rapid phase of the triphasic reduc- 
tion. The absence of a reoxidation phase suggests that 
menaquinone cannot reoxidize the b cytochromes at 
center N, or that reoxidation through center N is slow 
relative to the rate of reduction through center P, 
consistent with the low potential of menaquinone 
relative to cytochrome b~. 
The crystal structure of the Rieske iron-sulfur 
protein [5] and the crystal structures of the mito- 
chondrial cytochrome bc~ complexes [1,14,15] pro- 
vide an opportunity to test several aspects of iron- 
sulfur protein function in the protonmotive Q cycle 
mechanism [2,7,8]. We have used RMRSM analysis 
of pre-steady-state kinetics and steady-state kinetics 
measurements on bc 1 complexes containing site-di- 
rected mutants of the Rieske iron-sulfur protein to 
test the function of the high redox potential of the 
Rieske iron-sulfur cluster in the Q cycle mechanism 
[3]. The midpoint potential of the iron-sulfur cluster 
was systematically altered from +280 to + 105 mV 
by eliminating two hydrogen bonds, from a con- 
served serine and a conserved tyrosine, that otherwise 
facilitate electron delocalization from the reduced 
cluster. Eliminating the hydrogen bond from the 
hydroxyl group of Ser ls3 to S-1 of the cluster lowers 
the midpoint potential of the cluster by 130 mV, and 
eliminating the hydrogen bond from the hydroxyl 
group of Tyr185 to S v of Cys ]59 lowers the midpoint 
potential by 65 inV. Eliminating both hydrogen bonds 
has an approximately additive effect, lowering the 
midpoint potential by 180 inV. Ubiquinol-cyto- 
chrome c reductase activity of the bc I complex 
decreases with the decrease in midpoint potential, 
confirming that oxidation of ubiquinol by the iron- 
sulfur protein is the rate-limiting partial reaction in 
the bcj complex. 
The changes in cytochrome c reductase activity of 
the bc~ complex resulting from changes in the 
midpoint potential indicate that the midpoint potential 
of the iron-sulfur cluster extensively influences the 
activity of the bc ~ complex. This means that deproto- 
nation of ubiquinol to ubiquinol anion is either not a 
prerequisite to electron transfer or must occur at a 
much greater ate than electron transfer, otherwise the 
rate would be independent of the Rieske midpoint 
potential. As the midpoint potential of the Rieske 
protein increased from 220 to 280 mV, the cyto- 
chrome c reductase activity increased 2.5-fold [3]. If 
electron transfer from ubiquinol to cytochrome c~ can 
be interpreted by Marcus theory, the 2.5-fold change 
in rate per 60 mV change in potential is most easily 
explained if electron transfer to the iron-sulfur 
cluster is from a donor with a redox potential similar 
to that of the iron-sulfur cluster. Since the potential 
of the QH /Q couple is approximately -25  mV and 
that of the QH2/Q couple is approximately +90 mV 
[10], the observed changes in rate as a function of 
iron-sulfur protein potentials are more readily ex- 
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Fig. 6. Reduction of the cytochrome bc~ complex through center P and center N by menaquinot, in the absence of endogenous biquinone. Figure shows 
the time course of reduction of the cytochrome bc I complex isolated from a mutant yeast strain (ACoQ2) that lacks endogenous biquinone. The top panel 
shows reduction of 2 p~M bca complex by 50 >M menaquinol in the absence of inhibitors. The middle panel shows the inhibition of c~ reduction by 
stigmatellin, and the bottom panel shows the inhibition of b and c~ reduction by stigmatellin plus antimycin. 
plained if ubiquinol, and not ubiquinol anion, is the 
redox donor for the Rieske protein. 
Furthermore, deprotonation of ubiquinol, which 
has an estimated pKa=l l .25  [10], would require an 
extremely alkaline local environment on the iron- 
sulfur protein, to provide a binding site proximal to 
the iron-sulfur cluster, and would result in tight 
binding of ubiquinol anion in the absence of electron 
transfer. No such amino acid sequence conservation 
is observed in the iron-sulfur proteins sequenced to 
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date [2], and no high-affinity binding site for 
ubiquinol has ever been demonstrated. We suggest an 
alternative mechanism in which the protonated 
ubiquinol competitively displaces a proton from the 
imidazole nitrogen of one of the histidines that is a 
ligand to the iron-sulfur cluster and forms a quinol- 
imidazolate complex, and this complex is the electron 
donor to the redox active iron. This mechanism 
circumvents prerequisite deprotonation of ubiquinol. 
We are also testing whether conserved aromatic 
amino acids form a conduit or otherwise facilitate 
electron transfer from the iron-sulfur cluster to the 
surface of the iron-sulfur protein en route to the 
heme of cytochrome c~ [11]. Sequence alignments of 
all Rieske proteins characterized to date identify a 
maximum of 10 aromatic amino acids that are 
conserved, if conservative xchanges and a liberal 
allowance of sequence alignments are allowed. These 
correspond to Wl l l ,  Fl l7,  W152, F173, W176, 
F177, H184, Y185, Y205, and F207 in the S. cere- 
visiae Rieske iron-sulfur protein. We have con- 
structed yeast mutants in which each of these aro- 
matic residues in the Rieske iron-sulfur protein has 
been replaced with a non-aromatic residue, and in 
some instances yeast mutants with combined replace- 
ments have been constructed. Preliminary analysis of 
the bc r complexes from these mutants uggests that 
there is no obligatory electron transfer conduit 
through aromatic residues in the S. cerevisiae Rieske 
iron-sulfur protein. Small changes in the ubiquinol- 
cytochrome c reductase activities of the bc 1 complex- 
es containing the W176L, F177L, and the W176L, 
F177L forms of the Rieske protein indicate that any 
facilitation of electron transfer from 7r orbitals in 
aromatic amino acids results in only modest rate 
enhancements. 
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